Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

95 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Sodium-glucose Cotransporter-2 Inhibitors in Primary and Secondary Prevention of Cardiovascular and Renal Outcomes in Patients with Type 2 Diabetes Mellitus: A Meta-analysis.
Kovil R, Chawla M, Shah T, Sahoo A, Makkar B, Kesavadev J, Seshadri K, Tiwaskar M, Rajput R, Phatak S, Majumdar S, Gupta S. Kovil R, et al. Among authors: seshadri k. J Assoc Physicians India. 2022 Aug;70(8):11-12. doi: 10.5005/japi-11001-0076. J Assoc Physicians India. 2022. PMID: 36082726
An observational, cross-sectional study to assess the prevalence of chronic kidney disease in type 2 diabetes patients in India (START -India).
Prasannakumar M, Rajput R, Seshadri K, Talwalkar P, Agarwal P, Gokulnath G, Kotak B, Raza A, Vasnawala H, Teli C. Prasannakumar M, et al. Among authors: seshadri k. Indian J Endocrinol Metab. 2015 Jul-Aug;19(4):520-3. doi: 10.4103/2230-8210.157857. Indian J Endocrinol Metab. 2015. PMID: 26180769 Free PMC article.
Evidence-based recommendations for insulin intensification strategies after basal insulin in type 2 diabetes.
Ghosh S, Unnikrishnan AG, Saboo B, Kesavadev J, Aravind SR, Bajaj S, Rajput R, Seshadri K, Verma N, Gupta A, Makkar BM, Saikia M, Kale S, Damodaran S, Dengra A, Eashwar TKM, Maheshwari A, Pendsey S, Phatak SR, Sharma SK, Singh SK, Ramachandran A, Zargar AH, Joshi SR, Sadikot SM. Ghosh S, et al. Among authors: seshadri k. Diabetes Metab Syndr. 2017 Nov;11 Suppl 1:S507-S521. doi: 10.1016/j.dsx.2017.03.045. Epub 2017 Apr 5. Diabetes Metab Syndr. 2017. PMID: 28433618 Review.
Lipid Association of India Expert Consensus Statement on Management of Dyslipidemia in Indians 2016: Part 1.
Iyengar SS, Puri R, Narasingan SN, Wangnoo SK, Mohan V, Mohan JC, Misra A, Sriram U, Dalal JJ, Gupta R, Prabhakar D, Kerkar P, Zargar AH, Kasliwal RR, Mehrotra R, Kumar S, Chakraborty R, Chadha M, Daga MK, Seshadri K, Paul J, Kavalipati N, Kapoor D, Narain VS, Rastogi A, Muruganathan A, Gupta A, Murthy S, Bordoloi N, Sahoo PK, Agarwal RK, Chag M, Rajput R, Melinkeri RP. Iyengar SS, et al. Among authors: seshadri k. J Assoc Physicians India. 2016 Mar;64(3 suppl):7-52. J Assoc Physicians India. 2016. PMID: 28762263 No abstract available.
Best Practices and Tools for Titrating Basal Insulins: Expert Opinion from an Indian Panel via the Modified Delphi Consensus Method.
Jain SM, Seshadri K, Unnikrishnan AG, Chawla M, Kalra P, Vipin VP, Ravishankar E, Chordia J, Das S, Wasir J, Bandookwala SM, Deka N, Agarwal G, Vijaykumar G, Erande S. Jain SM, et al. Among authors: seshadri k. Diabetes Ther. 2020 Mar;11(3):621-632. doi: 10.1007/s13300-020-00770-9. Epub 2020 Feb 3. Diabetes Ther. 2020. PMID: 32009224 Free PMC article. Review.
Prescribing Patterns and Response to Antihyperglycemic Agents Among Novel Clusters of Type 2 Diabetes in Asian Indians.
Anjana RM, Siddiqui MK, Jebarani S, Vignesh MA, Kamal Raj N, Unnikrishnan R, Pradeepa R, Panikar VK, Kesavadev J, Saboo B, Gupta S, Sosale AR, Seshadri KG, Deshpande N, Chawla M, Chawla P, Das S, Behera M, Chawla R, Nigam A, Gupta A, Kovil R, Joshi SR, Agarwal S, Bajaj S, Pearson ER, Doney ASF, Palmer CNA, Mohan V. Anjana RM, et al. Among authors: seshadri kg. Diabetes Technol Ther. 2022 Mar;24(3):190-200. doi: 10.1089/dia.2021.0277. Epub 2022 Jan 5. Diabetes Technol Ther. 2022. PMID: 34609928
SGLT2i as a First-line Antihyperglycemic in the Management of Type 2 Diabetes in the Context of Indians: A Systematic Review and Consensus.
Singh AK, Misra A, Das AK, Behl A, Srivastava A, Paneerselvam A, Chidambaram B, Saboo B, Sethi B, Makkar BM, Bantwal G, Thacker H, Panda J, Kesavadev J, Seshadri KG, Tiwaskar M, Shunmugavelu M, Sahay R, Das S, Agarwal S, Shaikh S, Sharma SK, Gupta S, Bhattacharyya S, Mohan V, Gunupati VK. Singh AK, et al. Among authors: seshadri kg. J Assoc Physicians India. 2023 Dec;71(12):62-74. doi: 10.59556/japi.71.0422. J Assoc Physicians India. 2023. PMID: 38736056
95 results